Delivery Order SPE2DB20D1004-SPE2DB23FG3J6

Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,396.18 firm fixed-price delivery order is for 4,562,345,313 units of 10 mg Simvastatin tablets. The contract has an ultimate completion date of September 29, 2023 and is not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $2,224.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,565,239,896 units of Simvastatin 20 mg tablets and has a firm fixed-price pricing type. The award was not associated with any set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,746.54 firm fixed-price delivery order contract is for the supply of 4,564,978,157 units of Simvastatin 20 mg tablets. The contract has a ceiling value of $4,746.54 and a completion date of June 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
The Defense Logistics Agency (DLA) awarded a $1,243.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,560,703,374 Simvastatin 40 mg tablets. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of 4,564,659,961 tablets of Simvastatin 20 mg to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, and has a ceiling value of $2,565.06. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D1050|SPE2DB25FH48J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of 4,567,138,427 tablets of 40 mg Simvastatin, a generic cardiovascular medication. The $2,679.43 firm-fixed-price delivery order has a completion date of February 4, 2025 and is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,562,234,391 tablets of 40 mg Simvastatin, a prescription medication. The contract has a ceiling value of $4,913.76 and a period of performance ending on September 20, 2023. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 4,566,816,327 units of Simvastatin 40 mg tablets. The fixed-price delivery order is valued at $4,772.19 and has an ultimate completion date of January 2, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of 4,562,331,338 units of SIMVASTATIN 20 MG TABLET 1000S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The fixed-price delivery order, valued at $2,140.68, has an ultimate completion date of September 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which is a part of the...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL24M, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,418.34 firm fixed-price delivery order is for the supply of 4,563,653,743 units of Simvastatin 40 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG3J6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $5,005.88 firm-fixed-price delivery order (SPE2DB20D1004|SPE2DB23FG3J6) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for 4,561,708,082 units of Simvastatin 20 mg tablets. This delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:57 AM